Related Practices

Why Leading Pharmaceutical Companies Turn to Axinn

Axinn offers the leading pharmaceutical practice in the country. Our team combines its deep substantive patent law and litigation experience with its FDA and antitrust expertise to offer clients a unique end-to-end solution. Whether it’s leading a patent trial on a blockbuster product or navigating the complex FDA regulatory regime, Axinn provides a one-stop-shop to enable pharmaceutical clients to bring their products to market in the most economically-beneficial manner.

Axinn’s pharmaceutical practice is among the most experienced in the country. Axinn worked on eight of 2018’s Top 10 Generic Drugs (by savings), according to the AAM Generic Drug & Biosimilars Access & Savings Report. Over the past 10 years alone, Axinn has served as lead trial counsel in over 120 Paragraph IV litigations involving products with over $100 billion in annual sales. Members of the practice apply their profound technical knowledge and hands-on industry experience to provide our clients with an integrated approach to launch their products. Many of the members of the practice have advanced degrees and undergraduate degrees in such areas as biology, molecular biology, chemistry, microbiology, biochemistry, neurobiology, and molecular and cell biology.

We Know Pharma . . . and They Know Us

Our clients have included some of the largest pharmaceutical companies in the world, including:

Counsel to Generic Pharma on Some of the Industry’s Biggest Products*

* Annual brand sales prior to generic entry

Representative experience includes:


By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.